Mitra Biotech Stock
personalized cancer treatment
About Mitra Biotech Stock
Mitra is an innovative biotechnology company dedicated to discover tools to segregate patients for existing and developing anti-cancer treatments. Mitra is addressing significant challenges in personalized cancer medicine with dedicated scientists educated and trained in world famous institutes. Mitra’s discoveries to detect and manage cancer have practical applications and will be moved from the bench to bedside.
Investors
Sands Capital Ventures
AppDynamics, DoorDash, DocuSign, UiPath, MuleSoft, Funding Circle, Scopely, Upgrade, Mitra Biotech
Funding History
| April 2010 | $2.2M |
|---|---|
| October 2013 | $4.9M |
| August 2016 | $27.4M |
| July 2018 | $40.0M |
Management
Chief Commercial Officer
Parker Cassidy
Co-Founder & CSO
Pradip Majumder
Co-Founder, President & CEO
Mallik Sundaram
Other Companies
EquityZen does not have an affiliation with, formal relationship with, or endorsement from Mitra Biotech or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
